| Gender Preference | None |
| Age Group | 40 - 99 years |
| Research Start Date | August 31, 2012 |
| Research End Date | February 28, 2013 |
| Principal Investigator | Enrique Leira, MD |
| Description |
- Purpose: is to test the effectiveness of a new medication called pioglitazone for preventing future strokes and heart attacks among persons with a recent stroke or TIA.
- Eligibility: persons 40 years of age or older who have had a stroke or TIA in the past 6 months and are not diabetic are eligible.
- Duration and Involvement: patients will be asked to take the study medication daily (pioglitazone 45 mg vs. placebo) and return to clinic once per year for study visits. Participation will last approximately 5 years.
|
| Contact Info | Jeri Sieren, RN at 319-356-8744 |
| Keywords | span itemProp='description'>IRIS study ; Neurology ; |